These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15537514)

  • 41. Cognitive dysfunction and its clinical and radiological determinants in patients with symptomatic arterial disease and diabetes.
    Tiehuis AM; Mali WP; van Raamt AF; Visseren FL; Biessels GJ; van Zandvoort MJ; Kappelle LJ; van der Graaf Y;
    J Neurol Sci; 2009 Aug; 283(1-2):170-4. PubMed ID: 19268970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relation of cerebral small-vessel disease and brain atrophy to mild Parkinsonism in the elderly.
    Reitz C; Trenkwalder C; Kretzschmar K; Roesler A; V Eckardstein A; Berger K
    Mov Disord; 2006 Nov; 21(11):1914-9. PubMed ID: 16960865
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of white matter hyperintensities and medial temporal lobe atrophy in age-related executive dysfunctioning.
    Oosterman JM; Vogels RL; van Harten B; Gouw AA; Scheltens P; Poggesi A; Weinstein HC; Scherder EJ
    Brain Cogn; 2008 Nov; 68(2):128-33. PubMed ID: 18450353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated plasma homocysteine is associated with increased brain atrophy rates in older subjects with mild hypertension.
    Narayan SK; Firbank MJ; Saxby BK; Stansby G; Hansrani M; O'Brien JT; Ford GA
    Dement Geriatr Cogn Disord; 2011; 31(5):341-8. PubMed ID: 21597295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of homocysteine-related subcortical brain atrophy with white matter lesion volume and cognition in healthy aging.
    Song H; Bharadwaj PK; Raichlen DA; Habeck CG; Huentelman MJ; Hishaw GA; Trouard TP; Alexander GE
    Neurobiol Aging; 2023 Jan; 121():129-138. PubMed ID: 36436304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Homocysteine as a risk factor for cognitive impairment in stroke patients.
    Sachdev PS; Valenzuela MJ; Brodaty H; Wang XL; Looi J; Lorentz L; Howard L; Jones M; Zagami AS; Gillies D; Wilcken DE
    Dement Geriatr Cogn Disord; 2003; 15(3):155-62. PubMed ID: 12584431
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Small Vessel Cerebrovascular Pathology Identified by Magnetic Resonance Imaging Is Prevalent in Alzheimer's Disease and Mild Cognitive Impairment: A Potential Target for Intervention.
    Scott TM; Bhadelia RA; Qiu WQ; Folstein MF; Rosenberg IH
    J Alzheimers Dis; 2018; 65(1):293-302. PubMed ID: 30040728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes.
    de Bresser J; Tiehuis AM; van den Berg E; Reijmer YD; Jongen C; Kappelle LJ; Mali WP; Viergever MA; Biessels GJ;
    Diabetes Care; 2010 Jun; 33(6):1309-14. PubMed ID: 20299484
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyperhomocysteinemia is associated with volumetric white matter change in patients with small vessel disease.
    Wong A; Mok V; Fan YH; Lam WW; Liang KS; Wong KS
    J Neurol; 2006 Apr; 253(4):441-7. PubMed ID: 16267639
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of Homocysteine with Cerebral Hemodynamic Abnormality, Endothelial Dysfunction Markers, and Cognition Impairment in Patients with Traumatic Brain Injury.
    Hatefi M; Behzadi S; Dastjerdi MM; Ghahnavieh AA; Rahmani A; Mahdizadeh F; Hafezi Ahmadi MR; Asadollahi K
    World Neurosurg; 2017 Jan; 97():70-79. PubMed ID: 27693818
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-
    Włoczkowska O; Perła-Kaján J; Smith AD; de Jager C; Refsum H; Jakubowski H
    Alzheimers Dement (N Y); 2021; 7(1):e12159. PubMed ID: 33816764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals.
    Sachdev PS; Valenzuela M; Wang XL; Looi JC; Brodaty H
    Neurology; 2002 May; 58(10):1539-41. PubMed ID: 12034795
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduced N-acetylaspartate is consistent with axonal dysfunction in cerebral small vessel disease.
    Nitkunan A; Charlton RA; Barrick TR; McIntyre DJ; Howe FA; Markus HS
    NMR Biomed; 2009 Apr; 22(3):285-91. PubMed ID: 19009567
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MRI correlates of executive dysfunction in patients with ischaemic stroke.
    Vataja R; Pohjasvaara T; Mäntylä R; Ylikoski R; Leppävuori A; Leskelä M; Kalska H; Hietanen M; Aronen HJ; Salonen O; Kaste M; Erkinjuntti T
    Eur J Neurol; 2003 Nov; 10(6):625-31. PubMed ID: 14641506
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sleep mediates the association between homocysteine and oxidative status in mild cognitive impairment.
    Sanchez-Espinosa MP; Atienza M; Cantero JL
    Sci Rep; 2017 Aug; 7(1):7719. PubMed ID: 28798397
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Homocysteine, cognition and brain white matter hyperintensities.
    Fuh JL
    Acta Neurol Taiwan; 2010 Sep; 19(3):150-2. PubMed ID: 20824535
    [No Abstract]   [Full Text] [Related]  

  • 57. Elevated Serum Homocysteine Associated with Distal Type of Single Small Subcortical Infarction.
    Liu C; Gao Y; Song B; Wang Y; Pei L; Li S; Xu Y; Li Y
    Curr Neurovasc Res; 2020; 17(5):629-635. PubMed ID: 33121410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cognition and white matter lesions.
    Desmond DW
    Cerebrovasc Dis; 2002; 13 Suppl 2():53-7. PubMed ID: 11901244
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cognitive performance after small strokes correlates with ischemia, not atrophy of the brain.
    Meyer JS; Obara K; Muramatsu K; Mortel KF; Shirai T
    Dementia; 1995; 6(6):312-22. PubMed ID: 8563784
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interactive effects of elevated homocysteine and late-life depression on cognitive impairment.
    Zhou H; Zhong X; Chen B; Wu Z; Zhang M; Mai N; Peng Q; Chen X; Ouyang C; Liang W; Dai C; Huang X; Zhang W; Ning Y
    J Affect Disord; 2020 Dec; 277():212-217. PubMed ID: 32829197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.